WBB Securities Sponsors BioCentury’s Future Leaders in the Biotech Industry Conference
Posted: Mar 20th, 2015In: Press ReleasesToday WBB Securities sponsored BioCentury’s Future Leaders in the Biotech Industry conference held at the Millennium Broadway Hotel and Conference Center in New York City.
Read More about WBB Securities Sponsors BioCentury’s Future Leaders in the Biotech Industry ConferenceWBB Securities Co-Manages $84 Million Public Offering for Omeros Corporation
Posted: Feb 4th, 2015In: Press ReleasesWBB Securities acted as co-manager to a transaction for Omeros Corporation in an underwritten public offering that closed on February 3, 2015.
Read More about WBB Securities Co-Manages $84 Million Public Offering for Omeros CorporationWBB Securities Co-Manages $10.3MM Public Offering for CytoSorbents Corporation
Posted: Jan 15th, 2015In: Press ReleasesCytoSorbents announces closing of public offering to fund ongoing commercial and clinical activities
Read More about WBB Securities Co-Manages $10.3MM Public Offering for CytoSorbents CorporationWBB Securities Announces Michelle Thomas Elected to FINRA District 2 Committee
Posted: Dec 8th, 2014In: Press ReleasesWBB Securities is pleased to announce that Michelle Thomas, CRCPhas been elected to the FINRA District 2 Committee where she will serve a three-year term.
Read More about WBB Securities Announces Michelle Thomas Elected to FINRA District 2 CommitteeWBB Securities Acts as Financial Advisor to NeoStem, Inc. on $20MM Debt Facility
Posted: Sep 29th, 2014In: Press ReleasesNeoStem announces $20 million term loan financing from Oxford Finance LLC
Read More about WBB Securities Acts as Financial Advisor to NeoStem, Inc. on $20MM Debt FacilityWBB Securities Sponsors BioCentury’s 21st Annual NewsMakers Conference
Posted: Sep 29th, 2014In: Press ReleasesExecutive Teams of Emerging Biotech Companies Present to Investor Community
Read More about WBB Securities Sponsors BioCentury’s 21st Annual NewsMakers ConferenceWBB Securities Acts as Co-manager to TetraLogic Pharmaceuticals on $47MM Convertible Senior Notes Transaction
Posted: Jun 25th, 2014In: Press ReleasesWBB Securities acted as co-manager on a convertible senior notes transaction for TetraLogic Pharmaceuticals, Inc.
Read More about WBB Securities Acts as Co-manager to TetraLogic Pharmaceuticals on $47MM Convertible Senior Notes TransactionWBB Securities Acts as Exclusive Placement Agent to Cytori Therapeutics
Posted: Jun 6th, 2014In: Press ReleasesWBB Securities acted as exclusive placement agent on a registered direct financing for Cytori Therapeutics, a clinical phase regenerative medicine company.
Read More about WBB Securities Acts as Exclusive Placement Agent to Cytori TherapeuticsWBB Securities Named Co-Manager on Omeros Corporation Underwriting
Posted: Mar 19th, 2014In: Press ReleasesOmeros closes $40.25 million in underwritten public offering
Read More about WBB Securities Named Co-Manager on Omeros Corporation UnderwritingWBB Securities Retained as Financial Advisor to Athersys, Inc.
Posted: Jan 10th, 2014In: Press ReleasesAthersys announces $20.5 million registered direct financing to fund ongoing clinical trials in regenerative medicine
Read More about WBB Securities Retained as Financial Advisor to Athersys, Inc.